These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3283725)

  • 1. [Use of human insulin preparations in the treatment of patients with insulin-dependent diabetes mellitus].
    Perelygina AA; Smirnova OM; Lobanova AM; Gorelysheva VA
    Probl Endokrinol (Mosk); 1988; 34(1):3-5. PubMed ID: 3283725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ultratard HM, a new human insulin. Advantages as compared to current preparations?].
    Saner B; Fankhauser S
    Schweiz Med Wochenschr; 1986 Jan; 116(4):116-9. PubMed ID: 3513303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of monopeak insulin preparations in patients with type-1 diabetes mellitus].
    Pliats OM; Perelygina AA; Starosel'tseva LK
    Probl Endokrinol (Mosk); 1984; 30(3):3-6. PubMed ID: 6377294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical comparison of purified bovine and purified porcine insulins.
    Olczak SA; Greenwood RH
    Postgrad Med J; 1985 Jan; 61(711):15-8. PubMed ID: 3887349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin binding to erythrocytes in insulin dependent diabetics with different insulin requirement and insulin antibody titre.
    Turco GL; Bruni B; Brossa C; D'Alberto M; Grassi G; Gamba Ansaldi S; Censon A
    J Nucl Med Allied Sci; 1984; 28(3):149-55. PubMed ID: 6397582
    [No Abstract]   [Full Text] [Related]  

  • 7. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effects of the transition from animal insulin to biosynthetic human insulin].
    Gatti A; Dell'Aversano R; Monda M; Bonavita M; Bocchino C; Giacometti F; Carleo R
    Boll Soc Ital Biol Sper; 1987 Jul; 63(7):597-604, 610-1. PubMed ID: 3311081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of domestic human insulin in patients with type I diabetes mellitus].
    Balabolkin MI; Poliakova IA; Mamaeva GG
    Probl Endokrinol (Mosk); 1993; 39(4):13-4. PubMed ID: 8415519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinkinetic and -dynamic in diabetic patients under insulin pump therapy after injections of human insulin or the insulin analogue (B28Asp).
    Wiefels K; Hübinger A; Dannehl K; Gries FA
    Horm Metab Res; 1995 Sep; 27(9):421-4. PubMed ID: 8557242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circulating immune complexes and insulin-binding capacity of the serum of diabetics].
    Vel'bri SK; Lilleorg AL; Kerge IaKh
    Probl Endokrinol (Mosk); 1986; 32(2):25-8. PubMed ID: 3520540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
    Goicolea I; Quiroga A; Vazquez JA
    Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies].
    Vandeleene B; Ketelslegers JM; Lambert AE
    Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-insulin, proinsulin, pancreatic polypeptide, glucagon and somatostatin antibodies in patients with insulin-dependent diabetes mellitus treated with conventional insulin preparations].
    Dominiak K; Gembal M; Horoszek-Maziarz S; Wójcikowski C
    Endokrynol Pol; 1987; 38(4):281-90. PubMed ID: 2900755
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin--binding antibodies in Nigerian diabetic patients.
    Bella AF; Adetuyibi A
    West Afr J Med; 1990; 9(4):291-4. PubMed ID: 2083207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous plasma insulin in a juvenile diabetic after ten years of insulin therapy.
    Johansen K
    Arch Intern Med; 1971 Jan; 127(1):139-40. PubMed ID: 5538984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.